FDA Investigator William R Chang

William R Chang has inspections in 3 countries as of 01 Dec 2023. William R Chang has collaborated with a combinined 1892 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
58
Last Inspection Date:
01 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
100004220
Country:
United States of America, Germany, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
Addam S Reynolds, Adena S Yau, Adetutu M Gidado, Alberto A Viciedo, Allen Lou, Amy L Singer, Amy M Codella, Amy M Cramer, Ana S Cabrera, Andrew J Garufi, Anthony J Donato, Barbara J Wilimczyk, Barbara Jwilimczyk Macri, Brenda L Reihing, Byungja E Marciante, Charles J Chacko, Colin E Tack, Cynthia L Gorveatt, Daniel J Grabicki, Daniel R Tammariello, Dave M Deroche, David H Smith, Dawn L Wydner, Deborah A Nebenzahl, Dennis G Kawabata, Dennis R Hock, Dhaval H Patel, Diane B Radice, Doreen P Gubbay, Douglas C Kovacs, Emest F Bizjak, Emmanuel J Ramos, Eric J Cunningham, Eric Rothschild, Erin D Mccaffery, Esteban Beltran, Frank J Marciniak, Fred Razzaghi, Frederick Razzaghi, Gamal A Norton, Gladys B Casper, Gobiga Vanniyasingam, Helen B Ricalde, Helen Verdel, James M Odonnell, James R Birkenstamm, Jonathan Ho, Jose M Cayuela, Joy Rkozlowski Klena, Justine Tomasso, Katelyn Astaub Zamperini, Kelli F Dobilas, Kelly Doremus, Kinh Q Mac, Kristen E Rescigno, Kristy A Zielny, Kwong P Lee, Lata C Mathew, PhD, Laura Fontan, MS, Lauren L Vajo, LCDR Matthew J Morrison, Li Li, Lisa Mathew, Loretta Nemchik, Margaret M Sands, Maria Estrella, Marjorie L Davis, Matthew W Kyle, Melissa A Freeman, Melissa A Zuppe, Meredith L Sheridan, Michael R Klapal, Michael Serrano, Michelle L Johnson, Monica L Gutierrez, Monika Borkowska, Naakesh N Gomanie, Nancy F Scheraga, Nancy L Rolli, Nancy M Espinal, Nicholas A Violand, Niketa Patel, Paul L Bellamy, Peter R Lenahan, Phillip M Pontikos, Regina T Brown, Richard K Vogel, Richard L Rutherford, Ricki A Chase, Robert G Ruff, Rose Ljean Mary, Russell J Glapion, Saleem A Akhtar, Sarah Forney, Shafiq S Ahadi, Shirley S Wen, Sinai Davis, Stephanie T Durso, Stephen J Mottola, Stephen R Souza, Tamil Arasu, PhD, Tania E Vizcaino, Tressa T Lewis, Valerie C Reed, Wayne J Meyer, Wendy R Blame, William Chang, Yehualashet A Gessesse, Yung W Chan, Yvins Dezan

William R Chang's Documents

Publish Date Document Type Title
February, 2019 FDA 483 TERRIFIC CARE LLC - Form 483, 2019-02-05
May, 2018 FDA 483 Actavis LLC - Form 483, 2018-05-07
July, 2019 FDA 483 Fujifilm Medical Systems U.S.A., Inc. - Form 483, 2019-07-02
April, 2023 FDA 483 Next Medical Products Company, LLC - Form 483, 2023-04-07
February, 2022 FDA 483 Epicare Acquisitions, Llc - Form 483, 2022-03-03
June, 2018 FDA 483 Response Datascope Corp. - Form 483R, 2018-07-02
June, 2022 FDA 483 SpaceBander Corporation - Form 483, 2022-06-02
February, 2018 FDA 483 Cosette Pharmaceuticals, Inc. - Form 483, 2018-02-15
July, 2019 FDA 483 Response Fujifilm Medical Systems U.S.A., Inc. - Form 483R, 2019-07-15
February, 2018 EIR Cosette Pharmaceuticals, Inc. - EIR, 2018-02-15
January, 2023 FDA 483 Addivation Medical - Form 483, 2023-01-12
June, 2018 FDA 483 Datascope Corp. - Form 483, 2018-06-11
May, 2022 FDA 483 B-ONE ORTHO, CORP. - Form 483, 2022-05-18
November, 2021 FDA 483 Accupac, LLC - Form 483, 2021-11-18
November, 2021 EIR Accupac, LLC - EIR, 2021-11-18
March, 2022 FDA 483 SwemCo Inc - Form 483, 2022-03-21
January, 2020 FDA 483 E-BEAM Services, Inc. - Form 483, 2020-01-27
September, 2022 FDA 483 Prince Sterilization Services LLC - Form 483, 2022-09-26
May, 2023 FDA 483 Ingen Orthopedics LLC - Form 483, 2023-05-03
October, 2019 FDA 483 Life Recovery Systems HD, LLC - Form 483, 2019-10-21
February, 2023 FDA 483 Ashland Specialty Ingredients, G.P. - Form 483, 2023-02-17
March, 2020 FDA 483 Pacon Manufacturing Corporation - Form 483, 2020-03-13
August, 2023 FDA 483 Burpee Materials Technology, LLC - Form 483, 2023-08-08

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more